电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

EIF2AK1 抗体 (AA 1-86)

EIF2AK1 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN7152137
发货至: 中国
  • 抗原 See all EIF2AK1 抗体
    EIF2AK1 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (EIF2AK1))
    抗原表位
    • 7
    • 7
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-86
    适用
    • 53
    • 26
    • 14
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    宿主
    • 53
    克隆类型
    • 53
    多克隆
    标记
    • 25
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    This EIF2AK1 antibody is un-conjugated
    应用范围
    • 32
    • 26
    • 22
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    交叉反应
    人, 大鼠
    纯化方法
    >95%, Protein G purified
    免疫原
    Recombinant Human Eukaryotic translation initiation factor 2-alpha kinase 1 protein (1-86AA)
    亚型
    IgG
    Top Product
    Discover our top product EIF2AK1 Primary Antibody
  • 应用备注
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
    限制
    仅限研究用
  • 状态
    Liquid
    缓冲液
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    储存液
    ProClin
    注意事项
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    -20 °C,-80 °C
    储存方法
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原
    EIF2AK1 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (EIF2AK1))
    别名
    EIF2AK1 (EIF2AK1 产品)
    别名
    HCR antibody, Hri antibody, HRI antibody, wu:fj97h09 antibody, zgc:153232 antibody, eukaryotic translation initiation factor 2 alpha kinase 1 antibody, eukaryotic translation initiation factor 2-alpha kinase 1 antibody, eukaryotic translation initiation factor 2 alpha kinase 1 L homeolog antibody, EIF2AK1 antibody, eif2ak1 antibody, Eif2ak1 antibody, eif2ak1.L antibody
    背景

    Background: Inhibits protein synthesis at the translation initiation level, in response to various stress conditions, including oxidative stress, heme deficiency, osmotic shock and heat shock. Exerts its function through the phosphorylation of EIF2S1 at \\\'Ser-48\\\' and \\\'Ser-51\\\', thus preventing its recycling. Binds hemin forming a 1:1 complex through a cysteine thiolate and histidine nitrogenous coordination. This binding occurs with moderate affinity, allowing it to sense the heme concentration within the cell. Thanks to this unique heme-sensing capacity, plays a crucial role to shut off protein synthesis during acute heme-deficient conditions. In red blood cells (RBCs), controls hemoglobin synthesis ensuring a coordinated regulation of the synthesis of its heme and globin moieties. Thus plays an essential protective role for RBC survival in anemias of iron deficiency. Similarly, in hepatocytes, involved in heme-mediated translational control of CYP2B and CYP3A and possibly other hepatic P450 cytochromes. May also contain ER stress during acute heme-deficient conditions (By similarity).

    Aliases: E2AK1_HUMAN antibody, EC 2.7.11.1 antibody, Eif2ak1 antibody, Eukaryotic translation initiation factor 2 alpha kinase 1 antibody, Eukaryotic translation initiation factor 2-alpha kinase 1 antibody, HCR antibody, Heme controlled repressor antibody, Heme regulated eukaryotic initiation factor eIF 2 alpha kinase antibody, Heme regulated inhibitor antibody, Heme regulated initiation factor 2 alpha kinase antibody, Heme regulated repressor antibody, Heme sensitive initiation factor 2a kinase antibody, Heme-controlled repressor antibody, Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase antibody, Heme-regulated inhibitor antibody, Hemin sensitive initiation factor 2 alpha kinase antibody, Hemin-sensitive initiation factor 2-alpha kinase antibody, HRI antibody, KIAA1369 antibody, PRO1362 antibody

    UniProt
    Q9BQI3
    途径
    Hepatitis C
You are here: